Data / Drug companies / Mylan Laboratories Limited
Mylan Laboratories Limited: 22 products in the FDA NDC directory, labeler code 65015
Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).
Mylan Laboratories Limited (labeler code 65015) lists 22 products in the FDA National Drug Code Directory. By type: 22 bulk ingredients. Its main marketing category is bulk ingredients. The newest product started marketing on July 15, 2019.
The request: Watch Mylan Laboratories Limited (FDA labeler code 65015): each new product listing and each discontinued product. $10 of work on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Labeler code
- 65015
- Products in commercial distribution
- 22
- Packages
- 22
- Finished drugs by generic name
- 0
- Prescription products
- 0
- Over the counter products
- 0
- Started marketing in the last 12 months
- 0
- Products with a marketing end date set
- 21
- Earliest marketing start
- December 10, 2014
- openFDA record search
- api.fda.gov
Products by marketing category
Share of the company's products in commercial distribution.
| Marketing category | Products | Share |
|---|---|---|
| Bulk ingredients | 21 | 95.5% |
| Drugs for further processing | 1 | 4.5% |
Products by type
| Type | Products | Share |
|---|---|---|
| Bulk ingredients | 22 | 100% |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Powder | 21 | 95.5% |
| Granule | 1 | 4.5% |
Newest products
By marketing start date.
| Product | Product NDC | Dosage form | Marketing category | Marketing start |
|---|---|---|---|---|
| Pomalidomide | 65015-893 | Powder | Bulk ingredients | July 15, 2019 |
| Macitentan | 65015-872 | Powder | Bulk ingredients | October 9, 2017 |
| Carvedilol phosphate | 65015-884 | Powder | Bulk ingredients | October 2, 2017 |
| Atorvastatin calcium | 65015-282 | Granule | Drugs for further processing | May 5, 2016 |
| Febuxostat | 65015-820 | Powder | Bulk ingredients | August 20, 2015 |
| Formoterol fumarate dihydrate | 65015-771 | Powder | Bulk ingredients | March 2, 2015 |
| Bosentan | 65015-770 | Powder | Bulk ingredients | February 24, 2015 |
| Paroxetine hydrochloride (anhydrous) | 65015-742 | Powder | Bulk ingredients | February 24, 2015 |
| Roflumilast | 65015-850 | Powder | Bulk ingredients | February 20, 2015 |
| Saxagliptin hydrochloride dihydrate | 65015-830 | Powder | Bulk ingredients | February 20, 2015 |
| Fingolimod hydrochloride | 65015-834 | Powder | Bulk ingredients | February 19, 2015 |
| Rotigotine | 65015-815 | Powder | Bulk ingredients | February 19, 2015 |
| Prasugrel hydrochloride | 65015-809 | Powder | Bulk ingredients | February 19, 2015 |
| Frovatriptan succinate monohydrate | 65015-780 | Powder | Bulk ingredients | February 19, 2015 |
| Tizanidine hydrochloride | 65015-777 | Powder | Bulk ingredients | February 19, 2015 |
| Rasagiline mesylate | 65015-775 | Powder | Bulk ingredients | February 19, 2015 |
| Proguanil hydrochloride | 65015-774 | Powder | Bulk ingredients | February 19, 2015 |
| Lenalidomide | 65015-772 | Powder | Bulk ingredients | February 19, 2015 |
| Pramipexole dihydrochloride monohydrate | 65015-768 | Powder | Bulk ingredients | February 19, 2015 |
| Epinephrine | 65015-846 | Powder | Bulk ingredients | February 18, 2015 |
| Dimethyl fumarate | 65015-844 | Powder | Bulk ingredients | February 18, 2015 |
| Epinephrine bitartrate | 65015-855 | Powder | Bulk ingredients | December 10, 2014 |
CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.